Results 71 to 80 of about 8,269 (200)
Evaluation of Methods for Identifying Human Monocytes by Flow Cytometry: TLR2 May be an Optimal Marker
Immunology, Volume 179, Issue 4, Page 682-694, December 2026.Monocytes play crucial roles in the pathobiology of a wide range of medical conditions, including infection, autoimmunity, cardiovascular disease and malignancies. Studies using flow cytometry revealed the complexity of monocyte biology, including the identification of three human monocyte subsets: classical (CD14pos CD16neg), intermediate (CD14pos ...Mie Wolff Kristensen, Katrine Skjøt Harbo, Thomas Vorup‐Jensen, Marianne Hokland, Morten Nørgaard Andersen +4 morewiley +1 more sourcePLC/JNK/ERK Ingenuity Pathway network containing differentially methylated genes between CMML patients and healthy donor samples.
, 2012 Red: hypermethylated in CMML samples; Green: hypomethylated in CMML samples.Jacqueline Boultwood (89560), Xabier Agirre (143264), Leire Garate (185178), Sara Alvarez (185180), José Ignacio Martín-Subero (185173), Felipe Prósper (138706), Nicolas Martínez-Calle (185171), Marta Fernandez-Mercado (143221), Sara Varea (185182), Juan Cruz Cigudosa (185183), María José Calasanz (143272), José Rifon (185181), Cristina Pérez (143252), Eric Delabesse (185176), James S. Wainscoat (89575), Victor Segura (46990), Nicholas C. P. Cross (185184) +16 morecore +1 more sourceCircular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression
Molecular Oncology, Volume 20, Issue 11, Page 2860-2875, November 2026.In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk +17 morewiley +1 more sourceChronische Myelomonozytäre Leukämie (CMML)
Chronische Myelomonozytäre Leukämien (CMML) werden basierend auf dem Nachweis von Monozyten im Blut verbunden mit Dysplasien im Knochenmark nach Ausschluss zahlreicher reaktiver Monozytosen diagnostiziert.Schweizerische Gesellschaft für Hämatologie, Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie, Lübbert, Michael, Schweizerische Gesellschaft für Medizinische Onkologie, Platzbecker, Uwe, Germing, Ulrich, Metzgeroth, Georgia, Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie, Blum, Sabine, Boch, Tobias, Pfeilstöcker, Michael +10 morecore +2 more sourcesTET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia.
PLoS ONE, 2012 Chronic myelomonocytic leukemia (CMML) has recently been associated with a high incidence of diverse mutations in genes such as TET2 or EZH2 that are implicated in epigenetic mechanisms. We have performed genome-wide DNA methylation arrays and mutational Cristina Pérez, Nicolas Martínez-Calle, José Ignacio Martín-Subero, Victor Segura, Eric Delabesse, Marta Fernandez-Mercado, Leire Garate, Sara Alvarez, José Rifon, Sara Varea, Jacqueline Boultwood, James S Wainscoat, Juan Cruz Cigudosa, María José Calasanz, Nicholas C P Cross, Felipe Prósper, Xabier Agirre +16 moredoaj +1 more sourceA New Clinically-Based Subclassification Proposal in CMML with Significant Prognostic Implications to Overcome the MDS/MPN Categorizing Dilemma
, 2016 Introduction: CMML is a clinically heterogeneous myeloid neoplasm hallmarked by the coexistence of dysplastic and proliferative patho-clinical features, which can include cytopenias, constitutional symptoms, splenomegaly, and leukocytosis.Aziz Nazha, Guillermo Garcia-Manero, Mrinal M Patnaik, Zachary Thompson, Ayalew Tefferi, Terra L. Lasho, Raajit K. Rampal, Elias J. Jabbour, Simona Colla, Hagop M. Kantarjian, Sekeres A Mikkael, Pierre Fenaux, Matias Eugenio Sanchez, Najla H Al Ali, Sally Killick, Simona Iacobelli, Francesco Onida, Rami S. Komrokji, Raphaël Itzykson, Alan F. List, Eric Solary and Eric Padron +20 morecore +2 more sourcesModulation of the RNA‐sensing RIG/MAVS pathway bypasses resistance to hypomethylating agents in acute myeloid leukemia
HemaSphere, Volume 10, Issue 11, November 2026.Abstract
DNA hypomethylating agents (HMAs) such as 5‐azacytidine (5‐AZA) are a cornerstone in the treatment of acute myeloid leukemia (AML), but development of resistance represents a major clinical challenge. Apart from epigenetic reprogramming of malignant cell clones, therapy with HMA is increasingly recognized to facilitate antineoplastic immunity, Nadia El Khawanky, Tatiana Nedelko, Giada Mandracci, Yunus Barth, Yuan Jiang, Kai Wang, Marc Rosenbaum, Christin Weiß, Christoph Geisenberger, Stefan Enßle, Ana M. Gómez Martínez, Sascha Göttert, Noomen Hamed, Julius C. Fischer, Jürgen Ruland, Dirk H. Busch, Hendrik Poeck, Katharina S. Götze, Anna L. Illert, Florian Bassermann, Simon M. Heidegger +20 morewiley +1 more source